Visakhapatnam, December 11–13: The Andhra Pradesh MedTech Zone (AMTZ) successfully hosted the three-day World Health Innovation Forum from December 11 to 13, drawing strong participation from healthcare and MedTech leaders across Asia, Europe, and African countries, alongside senior stakeholders from across India.The forum served as
New Delhi, 17 November 2025: The Association of Indian Medical Device Industry (AiMeD) has welcomed the Government of India’s landmark decision to withdraw multiple Quality Control Orders (QCOs) imposed in recent years on essential raw materials across polymer, plastic, textile, and chemical value chains. The
Delhi, November 14th, 2025: A seven-member delegation representing India’s medical devices industry was invited to a high-level Roundtable at the House of Lords in the UK Parliament to deliberate on emerging opportunities under the ongoing Comprehensive Economic and Trade Agreement (CETA). The session, jointly organised
New Delhi, October 10, 2025: The Association of Indian Medical Device Industry (AiMeD) has welcomed the Government of India’s latest step to speed up GST refunds for exporters and manufacturers. The new system, announced by the Central Board of Indirect Taxes and Customs (CBIC), allows 90%
India’s healthcare stakeholders — including hospitals, diagnostic chains, medical device firms, insurers and pharma groups — have responded positively to the rollout of GST 2.0, saying the tax changes announced under Prime Minister Narendra Modi’s leadership will alleviate cost pressures, expand access, and give a
New Delhi, September 16, 2025: The Association of Indian Medical Device Industry (AiMeD) has submitted recommendations to the Hon’ble Union Finance Minister and GST Council Chairperson, Smt. Nirmala Sitharaman, seeking balance GST reforms.AiMeD said the proposed reforms will help reduce healthcare costs for consumers. They
New Delhi: The Association of Indian Medical Device Industry (AiMeD) cautioned that changing GST rates for medical devices could impact domestic competitiveness if not carefully managed. Most devices now have a 12% GST, while inputs are taxed at 18%, causing an inverted duty structure and
Domestic manufacturers welcome greater market access, urge careful monitoring of import dynamics and regulatory alignment India’s medical device manufacturers have voiced their support for the proposed India-UK Free Trade Agreement (FTA), citing expanded opportunities for global collaboration and technology transfer. However, industry stakeholders also stressed the
Indian manufacturers urge for stricter scrutiny, citing data privacy, quality, and national security concernsIndia’s domestic medical technology (MedTech) manufacturers have raised serious alarms regarding the increasing penetration of Chinese medical devices in the Indian healthcare ecosystem, flagging major concerns about national security, data privacy, and
JATIN MAHAJANSecretary, Association of Diagnostics Manufacturers of India (ADMI)The perception that imported products are superior to Indian-made ones is deeply ingrained in the Indian psyche, rooted more in legacy and sentiment than in objective reality. However, this perception is increasingly outdated. India has made significant
